Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis

Biochemical Pharmacology
Benjamin A KefasMark Van de Casteele

Abstract

Metformin is an anti-diabetic drug that increases glucose utilization in insulin-sensitive tissues. The effect is in part attributable to a stimulation of AMP-activated protein kinase (AMPK). The present study demonstrates that metformin (0.5-2mM) also dose-dependently activates AMPK in insulin-producing MIN6 cells and in primary rat beta-cells, leading to increased phosphorylation of acetyl coA carboxylase (ACC). The maximal effect was reached within 12h and sustained up to 48h. After 24h exposure to metformin (0.5-1mM), rat beta-cells exhibited a reduced secretory and synthetic responsiveness to 10mM glucose, which was also the case following 24h culture with the AMPK-activator 5-amino-imidazole-4-carboxamide riboside (AICAR; 1mM). Longer metformin exposure (>24h) resulted in a progressive increase in apoptotic beta-cells as was also reported for AICAR; metformin-induced apoptosis was reduced by compound C, an AMPK-inhibitor. As with AICAR, metformin activated c-Jun-N-terminal kinase (JNK) and caspase-3 prior to the appearance of apoptosis. It is concluded that metformin-induced AMPK-activation in beta-cells reduces their glucose responsiveness and may, following sustained exposure, result in apoptosis.

References

Jan 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·C F SumR Taylor
Sep 1, 1985·Endocrinology·D G PipeleersW Gepts
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·F C SchuitD G Pipeleers
Jan 1, 1994·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C Wilcock, C J Bailey
Feb 29, 1996·The New England Journal of Medicine·C J Bailey, R C Turner
Oct 6, 1998·Annual Review of Biochemistry·D G HardieM Carlson
Apr 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·G da Silva XavierG A Rutter
Sep 28, 2000·Biochemical and Biophysical Research Communications·K KishiY Ebina
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Jan 28, 2003·Biochemical Society Transactions·L HueM H Rider
Feb 19, 2003·The Biochemical Journal·Gabriela da Silva XavierGuy A Rutter
Feb 12, 2004·American Journal of Physiology. Endocrinology and Metabolism·Isabelle LeclercGuy A Rutter

❮ Previous
Next ❯

Citations

Nov 20, 2004·Diabetologia·G A Rutter
Feb 21, 2006·Diabetologia·H RichardsonW M Macfarlane
Nov 26, 2009·The Journal of Biological Chemistry·Gordon P MearesJohn A Corbett
Jul 27, 2007·Journal of Toxicology and Environmental Health. Part a·Eun Ju BaeSang Geon Kim
Aug 18, 2010·Antioxidants & Redox Signaling·Petronela WeisováJochen H M Prehn
Jun 28, 2007·International Journal of Clinical Practice. Supplement·E Standl
Feb 19, 2009·American Journal of Physiology. Endocrinology and Metabolism·Victoria E Cotero, Vanessa H Routh
Mar 23, 2011·Molecular Cancer Research : MCR·Yongxian Zhuang, W Keith Miskimins
Aug 21, 2013·PloS One·Titia E Woudenberg-VrenkenHan Moshage
Oct 19, 2012·International Journal of Oncology·Hong-Quan DuongInsoo Bae
Jun 6, 2013·Mediators of Inflammation·Alessandra PudduFabrizio Montecucco
Feb 21, 2014·Biological & Pharmaceutical Bulletin·Jung Ok LeeSun Hwa Park
Apr 6, 2013·International Immunopharmacology·Kwi Young KangJi Hyeon Ju
May 26, 2012·Cellular and Molecular Life Sciences : CMLS·Tz-Chuen JuYijuang Chern
Sep 28, 2005·Expert Opinion on Investigational Drugs·Kathryn Aston-MourneySofianos Andrikopoulos
Feb 24, 2015·Current Medical Research and Opinion·Goksun AyvazUNKNOWN GALATA Study Group
Sep 26, 2015·Biomedical Reports·Mahmoud HashemitabarFreshteh Nejaddehbashi
Aug 23, 2008·The Journal of Pharmacy and Pharmacology·Dakshinamoorty Kandasamy ArulmozhiAddepalli Veeranjaneyulu
Jun 29, 2016·Cell Biochemistry and Biophysics·Yuxia XiongYejiang Zhou
May 10, 2011·Expert Opinion on Therapeutic Patents·Hee Yun, Joohun Ha
Apr 16, 2015·PloS One·Lingyu LuoZhijun Luo
May 6, 2016·Annual Review of Nutrition·Katleen LemaireFrans Schuit
Dec 6, 2011·Biochemical and Biophysical Research Communications·Tae Woo JungSeon Mee Kim
Aug 3, 2011·European Journal of Pharmacology·Kristina JanjetovicVladimir Trajkovic
Sep 11, 2004·Biochemical and Biophysical Research Communications·Xiaoqin XiangZhijun Luo
Jul 10, 2008·Molecular and Cellular Endocrinology·Guy A Rutter, Isabelle Leclerc
May 31, 2008·Toxicology and Applied Pharmacology·Yusuke NakatsuShigeru Ohta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis